Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Utz Brands
UTZ
$1.25B
| $14.4M | 0.01% |
1,044,441
-29,282
| -3% | -$407K |
|
352
Boot Barn
BOOT
$4.86B
| $14.4M | 0.01% |
209,187
+33,392
| +19% | +$2.86M |
|
353
Enviri
NVRI
$641M
| $14.4M | 0.01% |
2,019,046
-719,408
| -26% | -$6.48M |
|
|
HRT
354
DELISTED
HireRight Holdings Corporation
HRT
| $14.3M | 0.01% |
1,003,171
+27,864
| +3% | +$434K |
|
355
Canadian National Railway
CNI
$76.6B
| $14.2M | 0.01% |
125,852
-82,073
| -39% | -$9.59M |
|
356
Keurig Dr Pepper
KDP
$42.2B
| $14.1M | 0.01% |
399,337
-201,779
| -34% | -$7.32M |
|
357
Outset Medical
OM
$89.5M
| $14M | 0.01% |
62,934
-32,861
| -34% | -$14.1M |
|
358
Etsy
ETSY
$7.91B
| $13.8M | 0.01% |
188,722
-57,787
| -23% | -$5.28M |
|
359
Bio-Techne
TECH
$11.2B
| $13.8M | 0.01% |
159,028
-7,040
| -4% | -$660K |
|
360
Freeport-McMoran
FCX
$90.6B
| $13.7M | 0.01% |
467,899
-449,840
| -49% | -$18M |
|
|
ENLC
361
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $13.6M | 0.01% |
1,599,943
+441,654
| +38% | +$4.44M |
|
362
Neurocrine Biosciences
NBIX
$16.9B
| $13.6M | 0.01% |
+139,116
| New | +$12.8M |
|
363
Corning
GLW
$125B
| $13.4M | 0.01% |
426,261
-65,835
| -13% | -$2.27M |
|
364
National Vision
EYE
$1.78B
| $13.1M | 0.01% |
477,569
-378,869
| -44% | -$12.5M |
|
365
Madrigal Pharmaceuticals
MDGL
$10.9B
| $13.1M | 0.01% |
+182,446
| New | +$13.4M |
|
366
Agnico Eagle Mines
AEM
$74.5B
| $12.6M | 0.01% |
275,096
+117,959
| +75% | +$6.56M |
|
367
Lamb Weston
LW
$7.32B
| $12.6M | 0.01% |
175,698
+119,396
| +212% | +$7.89M |
|
368
Citi Trends
CTRN
$573M
| $12.5M | 0.01% |
529,136
-78,418
| -13% | -$2.21M |
|
369
Repligen
RGEN
$8.22B
| $12.4M | 0.01% |
76,573
-3,582
| -4% | -$567K |
|
370
Atlantic Union Bankshares
AUB
$6.08B
| $12.2M | 0.01% |
358,760
+9,862
| +3% | +$341K |
|
371
ON Semiconductor
ON
$32B
| $12.1M | 0.01% |
240,563
-345,513
| -59% | -$19.3M |
|
372
EOG Resources
EOG
$78.2B
| $11.8M | 0.01% |
106,433
-36,786
| -26% | -$4.57M |
|
373
Tractor Supply
TSCO
$16.7B
| $11.6M | 0.01% |
+299,375
| New | +$12.2M |
|
374
DT Midstream
DTM
$13.9B
| $11.6M | 0.01% |
235,738
-508,892
| -68% | -$27.8M |
|
375
Sysco
SYY
$39.8B
| $11.5M | 0.01% |
135,714
+62,221
| +85% | +$5.21M |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.